Delivery Order SPE2DB24D3013-SPE2DB25FFQEQ
- Not listed
- The Defense Logistics Agency awarded a $11,187.25 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, with performance occurring at the vendor's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a $18,263.06 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for September 15, 2025, and fulfillment occurring at the contractor's Conshohocken, Pennsylvania facility. The award represents a competitively awarded delivery order under AmerisourceBergen's existing pharmaceutical supply framework...
- The Defense Logistics Agency awarded a $23,543.70 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) valued at $12,222.99. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation, indicating the contract was competed openly among...
- The Defense Logistics Agency awarded a $35,816.58 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be executed from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $25,091.22 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for supply of RINVOQ ER 45 mg tablets (28-count unit dose packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $6,223.32. This non-set-aside delivery order is scheduled for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The award represents a discrete purchase order leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $10,858.62. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. The contract represents a firm fixed price delivery order with a ceiling value of $38,113.45 and an ultimate completion date of September 15, 2025. This non-set-aside award reflects AmerisourceBergen's continued role as a critical pharmaceutical supplier to the federal government, with performance taking place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is valued at $12,114.96 and utilizes firm fixed price terms, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQEQDelivery Order
The Defense Logistics Agency awarded a $3,342.01 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This is a firm fixed-price contract with performance to be completed by September 5, 2025, at AmerisourceBergen's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to compete effectively for federal pharmaceutical procurement requirements. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills delivery orders across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/4/25 |